Delivery Order SPE2DR25D2013-SPE2DR26F5QQU
- Not listed
- The Defense Logistics Agency awarded a $22,429.36 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors, with an ultimate completion date of September 17, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be supplied to the place of performance in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a $7,121.60 firm fixed price delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injectors, with a completion date of July 15, 2025. This non-set-aside award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of performance is AmerisourceBergen's corporate headquarters...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $7,922.90 firm fixed-price delivery order for Repatha 140 mg/mL SureClick auto-injectors, with an ultimate completion date of November 6, 2025. This competitively awarded contract, issued on November 5, 2025, represents a single delivery order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The order will be fulfilled from the vendor's Conshohocken, Pennsylvania facility, where...
- The Defense Logistics Agency awarded a $36,275.25 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors, with an ultimate completion date of December 9, 2025. This competitive award, issued on December 8, 2025, represents a firm fixed-price transaction with no set-aside designation. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations...
- The Defense Logistics Agency awarded a $62,369.85 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors, with an ultimate completion date of September 22, 2025. This non-set-aside competitive award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The IDC serves as a comprehensive global pharmaceutical...
- The Defense Logistics Agency awarded a $58,361.64 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injectors, with an ultimate completion date of November 10, 2025. This non-set-aside, competitively awarded contract carries firm fixed pricing and represents a single delivery order fulfillment under AmerisourceBergen's larger contract vehicle. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $3,783.70 to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injector medication, with an ultimate completion date of August 22, 2025. This non-set-aside contract was competitively awarded and represents a single delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The place of performance is the vendor's corporate office in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $24,262.73 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injectors, with performance in Conshohocken, Pennsylvania and completion by December 9, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military...
- The Defense Logistics Agency awarded a $64,840.72 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors, with performance at the contractor's Conshohocken, Pennsylvania facility. This non-competitive, firm fixed-price delivery order was awarded on November 17, 2025, with an ultimate completion date of November 18, 2025. The award represents a child delivery order issued under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a $15,402.81 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injectors, with a completion date of November 18, 2025. This delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The performance location is...
- SPE2DR25D2013Indefinite Delivery Contract
- SPE2DR25D2013-SPE2DR26F5QQUDelivery Order
The Defense Logistics Agency awarded a $17,611.34 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors, with an ultimate completion date of December 2, 2025. This non-set-aside, firm fixed-price delivery order leverages AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania, the company's headquarters location. As a major pharmaceutical distributor, AmerisourceBergen supplies critical medical commodities to support military and federal healthcare programs worldwide through its comprehensive IDC. This delivery order for Repatha, a PCSK9 inhibitor used to treat high cholesterol, exemplifies the company's role in providing specialty medications across multiple therapeutic domains to the Defense Health Agency and other federal healthcare systems. The firm fixed-price structure and competitive award reflect AmerisourceBergen's demonstrated capability to meet federal pharmaceutical procurement requirements through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $17.6k | 11/30/25 |